We market well.
Your agency should fully understand your product and the science. Then, there’s the marketplace. Grasping all three dynamics is a specialized field. Ours.
Our philosophy implies there are no excuses for boring and dull. The medical industry deserves better.
Spread the word. Big or small. Any time, any place. Right now, today. Don’t wait, hesitate or ruminate. We can help all medical companies. We’d like to make your brand our next success story.
NOW IN PROGRESS
World’s 2nd most popular
search engine? YouTube.
People are naturally interested in other humans and information.
Attract, educate and engage with videos that tell your story—just keep it brief.
recent work right here
GENEVA (Reuters) - The World Health Organization (WHO) said on Sunday it will create a contingency fund and an emergency workforce to respond quickly to crises after strong criticism of the agency's delay in confronting the Ebola epidemic.... (Reuters Health) - Women with breast cancer often don’t know what kind of tumors they have, a new study found.... NEW YORK (Reuters) - A new wave of experimental cancer drugs that directly recruit the immune system's powerful T cells are proving to be immensely effective weapons against tumors, potentially transforming the $100 billion global market for drugs that fight the disease.... (Reuters Health) - Twenty-somethings who were born prematurely are less likely to move in with a lover or have sex than their peers born at full term, Finnish researchers find.... (Reuters Health) - Despite moves by some states to allow recreational and medical use of marijuana, a large group of U.S. pediatricians says in a new statement that the substance should remain – for the most part – illegal.... (Reuters) - Regeneron Pharmaceuticals on Monday said U.S. health regulators accepted its application to review a potent cholesterol drug on a priority basis, potentially giving it the upper hand in a fierce race with Amgen to bring a new medicine from the promising class to market.... DAVOS, Switzerland (Reuters) - A steep fall in Ebola cases in Liberia will make it hard to prove whether experimental vaccines work in a major clinical trial about to start in the country, the head of the U.S. National Institutes of Health (NIH) said on Saturday.... LONDON (Reuters) - A British nurse who had been critically ill with Ebola after working in Sierra Leone has been discharged from a London hospital after making a full recovery.... MONROVIA (Reuters) - Liberia, once the epicenter of West Africa's deadly Ebola epidemic, has just five remaining confirmed cases of the disease, a senior health official said on Friday, highlighting the country's success in halting new infections.... DAVOS, Switzerland (Reuters) - Two new tools to fight AIDS should be available by 2030 in the form of a vaccine and new intense drug treatments, ending most cases of a disease that has killed millions in the past 30 years, Bill Gates said....